Your cart is empty.
Tecan uses cookies to improve our website. By continuing to browse our website, you accept our cookie policy.
Tecan uses cookies to improve our website. By continuing to browse our website, you accept our cookie policy.
The High Throughput Expression (HiTEL) Laboratory at the University of York is a service facility offering bespoke protein expression, using a Freedom EVO 200 workstation to meet its heavy demand for complete automation of high throughput cloning, expression and screening. "As a busy service laboratory, we rely on our automated systems to ensure reproducible cloning and protein expression for our clients," explained Experimental Officer Dr Rachel Adamson. "When the HiTEL facility was first established in early 2006, Tecan’s support allowed us to get our system set up and running very quickly, and we have been able to integrate a lot of different equipment into our workstation with the Company’s help."
"Automation of the cloning process minimizes variation between samples and eliminates operator errors," Rachel added. "This gives us a high level of confidence in the quality and quantity of protein we can produce for our customers. Equally importantly, it offers walkaway automation of time-consuming laboratory processes, allowing staff to perform other tasks and helping to accelerate our production."
About Tecan
Tecan (www.tecan.com) is a leading global provider of laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics. The company specializes in the development, production and distribution of instruments and automated workflow solutions for laboratories in the life sciences sector. With its subsidiary REMP (www.remp.com), Tecan is the market leader in automated laboratory storage and logistics systems. Its clients include pharmaceutical and biotechnology companies, university research departments, forensic and diagnostic laboratories. As an original equipment manufacturer, Tecan is also a leader in developing and manufacturing OEM instruments and components that are then distributed by partner companies. Founded in Switzerland in 1980, the company has manufacturing, research and development sites in both Europe and North America and maintains a sales and service network in 52 countries. In 2009, Tecan generated sales of CHF 392 million (USD 361.2 million; EUR 259.6 million). Registered shares of Tecan Group are traded on the SIX Swiss Exchange (TK: TECN/Reuters: TECZn.S/ ISIN CH0012100191).
For more information about Tecan, please contact
Tecan Trading AG
Tanja Kaiser
Seestrasse 103
CH-8708 Männedorf